The store will not work correctly when cookies are disabled.
3-(4-Imidazol-1-yl-butyl)-3H-quinazolin-4-one; 2HCl
ID: ALA310508
Chembl Id: CHEMBL310508
PubChem CID: 13952808
Max Phase: Preclinical
Molecular Formula: C15H16N4O
Molecular Weight: 268.32
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1c2ccccc2ncn1CCCCn1ccnc1
Standard InChI: InChI=1S/C15H16N4O/c20-15-13-5-1-2-6-14(13)17-12-19(15)9-4-3-8-18-10-7-16-11-18/h1-2,5-7,10-12H,3-4,8-9H2
Standard InChI Key: ITUAYMMBRIAMKG-UHFFFAOYSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 268.32 | Molecular Weight (Monoisotopic): 268.1324 | AlogP: 2.07 | #Rotatable Bonds: 5 |
Polar Surface Area: 52.71 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.55 | CX LogP: 1.43 | CX LogD: 1.39 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.67 | Np Likeness Score: -1.64 |
References
1. Wright WB, Tomcufcik AS, Chan PS, Marsico JW, Press JB.. (1987) Thromboxane synthetase inhibitors and antihypertensive agents. 4. N-[(1H-imidazol-1-yl)alkyl] derivatives of quinazoline-2,4(1H,3H)-diones, quinazolin-4(3H)-ones, and 1,2,3-benzotriazin-4(3H)-ones., 30 (12): [PMID:3681898] [10.1021/jm00395a016] |